Vaccinex, Inc.
VCNX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001205922
No open-market purchases or sales by Vaccinex, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Vaccinex, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 18 | 12 | −6 |
| Shares | 1.60M | 322.6K | −1.28M (−79.9%) |
| Value | $1.07M | $2.39M | +$1.32M (+124.2%) |
New holders (4)
Institutions that held Vaccinex, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 145,000 | $1.07M | 0.03% |
| Point72 Asset Management, L.P. | 116,546 | $863.6K | 0.00% |
| Tacita Capital Inc | 228 | $1.69K | 0.00% |
| Capital Advisors, Ltd. LLC | 13 | $0 | 0.00% |
Sold out (10)
Institutions that held Vaccinex, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Worth Venture Partners, LLC | 654,079 | $434.8K |
| Vanguard Group Inc | 48,221 | $32.1K |
| Renaissance Technologies LLC | 32,100 | $21.0K |
| Two Sigma Investments, LP | 16,159 | $10.7K |
| Geode Capital Management, LLC | 16,100 | $10.7K |
| XTX Topco Ltd | 11,737 | $7.80K |
| Cornerstone Planning Group LLC | 14 | $9 |
| JPMorgan Chase & Co | 10 | $7 |
| Bank of America Corp | 4 | $3 |
| Financial Connections Group, Inc. | 270 | $0 |